Around one-quarter of patients had recurrence of GV bleeding, mostly in the long-term follow-up period (more than one month), but none of the bleeding episodes led to death. Ascites and encephalopathy did not increase after the procedure, and there was a statistically significant improvement in serum albumin and INR levels postprocedure, suggesting a potential enhancement in hepatic synthetic function. Higher bilirubin levels (>3.5 mg/dL) were associated with higher mortality rate and bleeding risk, whereas Child-Pugh classification C was associated with higher mortality risk. Here, ALB is linked to Encephalopathy.